Halozyme Therapeutics, Inc. (HALO)

66.96 +1.85 (+2.84%) USD  |  NASDAQ  |  Dec 19, 13:11
More

Halozyme Therapeutics Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly)

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Per Share Quarterly) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
AIM ImmunoTech, Inc. Upgrade